Abstract
In the Heart and Estrogen/progestin Replacement Study (HERS), researchers found no cardiovascular benefit from combined estrogen-progesterone replacement therapy in women with known coronary heart disease (CHD; Journal Watch Jul 26 2002). Hard on the heels of the HERS findings, the data- and safety-monitoring committee of the Women's Health Initiative (WHI) halted, after a mean follow-up of 5.2 years, …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
